Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00501449
First received: July 12, 2007
Last updated: October 23, 2012
Last verified: October 2012

July 12, 2007
October 23, 2012
May 2007
May 2014   (final data collection date for primary outcome measure)
Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2. [ Time Frame: 3 Years ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00501449 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes
Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes

The specific aims of the study include:

  1. Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2.
  2. Evaluate MEN-specific distress as well as adherence to surveillance regimens among adults with MEN1 or MEN2, and identify associated with those outcomes.

The proposed cross-sectional study is intended to obtain information regarding current surveillance behaviors and other psychosocial outcomes among persons affected by the multiple endocrine neoplasia (MEN) 1 or MEN2, which are inherited conditions.

Study participants will include patients who have been seen previously at MDACC for evaluation of MEN1 or MEN2. Because this is the first time investigators are contacting these patients to invite them to participate in psychosocial research, the proposed study also will help determine the feasibility of conducting similar studies in the future.

Investigators anticipate that data gathered from this study will enhance existing knowledge about the psychological and behavioral aspects of the MEN syndromes, and will inform future research efforts directed toward this understudied population.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients with a diagnosis of MEN1 or MEN2.

Multiple Endocrine Neoplasia
Behavioral: Questionnaire
Mailed packets including cover letter describing purpose of study, study questionnaire, and return envelope.
Other Name: Survey
MEN
Patients with multiple endocrine neoplasia (MEN).
Intervention: Behavioral: Questionnaire
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
581
Not Provided
May 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Adults age 18 years or older, with a clinical or genetic diagnosis of MEN1 or MEN2
  2. Spouse, Significant Other, or Family Member who is at least 18 years of age and who is related to an individual who is a patient at MDACC and who has been diagnosed with MEN1.
  3. Ability to read and write English

Exclusion Criteria:

1) Inability to be contacted via mail (i.e., no contact information on record, incorrect address)

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00501449
2006-0783
No
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Not Provided
Principal Investigator: Susan Peterson, PhD M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
October 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP